Furthermore, as seen in ETV6/RUNX1-rearranged and hyperdiploid ALL, some patients with favorable genetics but slow MRD clearance can be cured by intensifying their post-remission chemotherapy [11,17,27]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.